title: Which level of immunosuppression is harmful for occult hepatitis B virus infection?
authors.forename: Ersan
authors.initials: E
authors.lastname: Ozaslan
mesh_terms: D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy*; D004279:DNA, Viral / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006509:Hepatitis B / Q000150:complications* / Q000175:diagnosis / Q000517:prevention & control; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D004279:DNA, Viral; D007166:Immunosuppressive Agents